Elsevier

Brain Research

Volume 1345, 23 July 2010, Pages 197-205
Brain Research

Research Report
Dynamic change of hydrogen sulfide during global cerebral ischemia–reperfusion and its effect in rats

https://doi.org/10.1016/j.brainres.2010.05.017Get rights and content

Abstract

Hydrogen sulfide (H2S) is a gaseous messenger and serves as an important neuromodulator in central nervous system. In the current study, we investigated the change of H2S and cystathionine β-synthase (CBS), an H2S-synthesizing enzyme at different time points of reperfusion following global cerebral ischemia in rats, and the effect of exogenous H2S on global cerebral ischemia–reperfusion injury. First, we used global cerebral ischemia–reperfusion model by occlusion of bilateral common carotid arteries and vertebral arteries. Next, we measured H2S levels in the hippocampus, cortex and plasma, the activity of H2S-synthesizing enzymes and expression of CBS mRNA and protein in the hippocampus and cortex at 12 h, 24 h, 48 h, 72 h and 7 days of reperfusion following 15 min cerebral ischemia. Second, we pretreated rats with different doses of sodium hydrogen sulfide (NaHS), an H2S donor and observed its effect on neuronal injury induced by 7 days of reperfusion after 15 min global cerebral ischemia. We found that when compared to sham group the amount of H2S in the hippocampus was increased significantly at 12 h of reperfusion after cerebral ischemia, markedly decreased at 24 h, restored to the same level as that in sham group at 48 h and maintained at 72 h and 7 days. The same change tendency in the levels of H2S was found in the cortex as described for the hippocampus. We found a similar change tendency in the activity of H2S-synthesizing enzymes, CBS mRNA and protein expression to that in the H2S level at different time points of reperfusion. Furthermore, while 180 μmol/kg NaHS pretreatment deteriorated the neuronal injury after global cerebral ischemia, 25 μmol/kg NaHS attenuated the neuronal injury. We suggest that a decrease of H2S level at 24 h of reperfusion after global cerebral ischemia may be involved in neuronal injury after cerebral ischemia and lower concentration rather than higher concentration of exogenous H2S may offer a protection against the neuronal injury induced by global cerebral ischemia–reperfusion.

Introduction

Hydrogen sulfide (H2S) has been known as a toxic gas and environment pollutant. However, in recent years, there has been growing interest in the potential role of H2S as an endogenous signaling molecule (Li and Moore, 2008, Wang, 2002). Endogenous H2S is mainly formed from cysteine by cystathionine β-synthase (CBS) and cystathionine γ-lyase (CSE). CBS is mainly expressed in the brain, peripheral nervous system, liver and kidney, whereas CSE is mostly found in the liver, vascular smooth muscle and endothelial cells (Lowicka and Beltowski, 2007). Recently, Kimura group reported that endogenous H2S could also be produced by 3-mercaptopyruvate along with cysteine aminotransferase along with cysteine aminotransferase in the brain (Shibuya et al., 2009). Physiological concentrations of H2S potentiate the activity of the N-methyl-d-aspartate receptor and enhance the induction of hippocampal long-term potentiation, a synaptic model of learning and memory (Abe and Kimura, 1996). Mutant mice lacking CSE display pronounced hypertension indicating that H2S is a physiologic vasorelaxant and regulator of blood pressure (Yang et al., 2008). These findings suggest that H2S may play an important physiological function in the central nervous system as an endogenous neuromodulator (Abe and Kimura, 1996).

In some pathological states, H2S-synthesizing enzymes are changed, and thereby H2S is changed, which may regulate the pathological state. There are some controversial effects of H2S in different pathological states. Exogenous H2S is of benefit in animal models of hypertensive diseases (Qingyou et al., 2004), while the inhibition of the endogenous synthesis of H2S is beneficial in various etiologies of shock (Hui et al., 2003, Mok et al., 2004). In ischemic conditions, inhibitors of H2S synthesis reduce the infarct volume caused by middle cerebral artery occlusion (Qu et al., 2006). However, H2S is produced by myocardial ischemia in sufficient amounts to limit myocardial injury (Geng et al., 2004, Sivarajah et al., 2006). Thus, H2S may have both beneficial and/or detrimental effects depending on what pathological state and/or what phase in a certain pathological state. However, changes of H2S in different phase during pathological state such as cerebral ischemia–reperfusion are not known. We therefore investigated the change of H2S and H2S-synthesizing enzymes at different time points of reperfusion following global cerebral ischemia in rats. Second, we determined the effect of different concentrations of exogenous H2S on neuronal injury induced by global cerebral ischemia–reperfusion.

Section snippets

The dynamic changes of H2S content in the hippocampus and cortex during global cerebral ischemia–reperfusion

To determine if H2S changes during global cerebral ischemia–reperfusion, we measured H2S amount at 12 h, 24 h, 48 h, 72 h and 7 days during reperfusion after global cerebral ischemia. As shown in Fig. 1A, there was no significant change in the H2S content in the hippocampus between normal group and sham group. The amount of H2S in the hippocampus at 12 h of reperfusion after cerebral ischemia increased significantly when compared with sham-operated controls. But H2S level markedly decreased at 24 h of

Discussion

There are several new findings in the present study. First, we demonstrated that H2S in the hippocampus and cortex exhibited dynamic changes during cerebral ischemia–reperfusion. Second, CBS mRNA expression, CBS protein expression and activity of H2S-synthesizing enzymes showed changes in parallel with H2S in the hippocampus and cortex during global cerebral ischemia–reperfusion. Third, higher concentration of NaHS markedly deteriorated neuronal injury induced by global cerebral

Animals and drugs

Male Sprague–Dawley rats (250 to 300 g) obtained from the Henan Province Laboratory Animal Center in China were housed under natural light/dark (12 to 12 h) cycle with food and water available ad libitum. All procedures were performed in accordance with institutional guidelines.

Sodium hydrosulfide (NaHS), an H2S donor, was obtained from Sigma (Sigma-Aldrich, St. Louis, MO) and dissolved in saline. NaHS was administered intraperitoneally 30 min prior to global cerebral ischemia. Control rats

References (52)

  • Z. Qingyou et al.

    Impact of hydrogen sulfide on carbon monoxide/heme oxygenase pathway in the pathogenesis of hypoxic pulmonary hypertension

    Biochem. Biophys. Res. Commun.

    (2004)
  • L. Rinaldi et al.

    Hydrogen sulfide prevents apoptosis of human PMN via inhibition of p38 and caspase 3

    Lab. Invest.

    (2006)
  • A. Slivka et al.

    Brain ischemia markedly elevates levels of the neurotoxic amino acid, cysteine

    Brain Res.

    (1993)
  • N.R. Sodha et al.

    Hydrogen sulfide therapy attenuates the inflammatory response in a porcine model of myocardial ischemia/reperfusion injury

    J. Thorac. Cardiovasc. Surg.

    (2009)
  • K. Abe et al.

    The possible role of hydrogen sulfide as an endogenous neuromodulator

    J. Neurosci.

    (1996)
  • C.L. Allen et al.

    Risk factors for ischaemic stroke

    Int. J. Stroke

    (2008)
  • J.D. Barks et al.

    Excitatory amino acids contribute to the pathogenesis of perinatal hypoxic–ischemic brain injury

    Brain Pathol.

    (1992)
  • M. Bhatia et al.

    Hydrogen sulphide is a mediator of carrageenan-induced hindpaw oedema in the rat

    Br. J. Pharmacol.

    (2005)
  • J. Diaz et al.

    Cerebral ischemia: new risk factors

    Cerebrovasc. Dis.

    (2004)
  • J.W. Elrod et al.

    Hydrogen sulfide attenuates myocardial ischemia–reperfusion injury by preservation of mitochondrial function

    Proc. Natl. Acad. Sci. U. S. A.

    (2007)
  • L.F. Hu et al.

    Hydrogen sulfide attenuates lipopolysaccharide-induced inflammation by inhibition of p38 mitogen-activated protein kinase in microglia

    J. Neurochem.

    (2007)
  • L.F. Hu et al.

    Hydrogen sulfide inhibits rotenone-induced apoptosis via preservation of mitochondrial function

    Mol. Pharmacol.

    (2009)
  • M. Ishigami et al.

    A source of hydrogen sulfide and a mechanism of its release in the brain

    Antioxid. Redox Signal.

    (2009)
  • K. Kang et al.

    Role of hydrogen sulfide in hepatic ischemia–reperfusion-induced injury in rats

    Liver Transpl.

    (2009)
  • Y. Kimura et al.

    Hydrogen sulfide increases glutathione production and suppresses oxidative stress in mitochondria

    Antioxid. Redox Signal.

    (2010)
  • I.P. Koerner et al.

    Induction of cerebral ischemic tolerance by erythromycin preconditioning reprograms the transcriptional response to ischemia and suppresses inflammation

    Anesthesiology

    (2007)
  • Cited by (83)

    • Sulfide catabolism in hibernation and neuroprotection

      2024, Nitric Oxide - Biology and Chemistry
    • Human-derived hair follicle stem cells and hydrogen sulfide on focal cerebral ischemia model: A comparative evaluation of radiologic, neurobehavioral and immunohistochemical results

      2023, Brain Research
      Citation Excerpt :

      These levels were also higher than the infarct volumes of the controls. In general, as others have highlighted that the effect of H2S in stroke is dose-dependent, that said, the low-dose of H2S in brain may play neuroprotective effect in stroke, our results regarding low-dose of H2S make its efficiancy questionable (Ren et al., 2010; Dou et al., 2016). The cranial infarct volume on the postoperative 28th day was significantly higher in the group in which H2S was administered alone compared to the HFBSC alone group.

    View all citing articles on Scopus
    View full text